Northeast Pharmaceutical Group Co Ltd Cash Flow Quality Index
Northeast Pharmaceutical Group Co Ltd cash flow quality index. Northeast Pharmaceutical Group Co Ltd (000597) has a Cash Flow Quality Index of 6.30x as of September 2025. Operating cash flow of CN¥274.09 Million exceeds net income of CN¥43.52 Million, indicating high earnings quality where cash backs reported profits. See 000597 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Northeast Pharmaceutical Group Co Ltd (1998–2025)
Cash flow quality index of Northeast Pharmaceutical Group Co Ltd from 1998 to 2025. Historical Cash Flow Quality Index for Northeast Pharmaceutical Group Co Ltd across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 000597 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Northeast Pharmaceutical Group Co Ltd Cash Flow Quality Index by Year (1998–2025)
Northeast Pharmaceutical Group Co Ltd cash flow quality index by year from 1998 to 2025. Year-by-year earnings quality comparison for Northeast Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Northeast Pharmaceutical Group Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.25x | CN¥1.11 Billion | CN¥260.07 Million | ▲ +129.8% |
| 2024 | 1.85x | CN¥758.76 Million | CN¥409.85 Million | ▲ +13.1% |
| 2023 | 1.64x | CN¥586.75 Million | CN¥358.46 Million | ▼ -47.3% |
| 2022 | 3.10x | CN¥1.11 Billion | CN¥357.05 Million | ▼ -60.3% |
| 2021 | 7.82x | CN¥746.51 Million | CN¥95.44 Million | ▼ -85.2% |
| 2020 | 52.73x | CN¥570.92 Million | CN¥10.83 Million | ▲ +2448.8% |
| 2019 | 2.07x | CN¥352.60 Million | CN¥170.44 Million | ▲ +46.1% |
| 2018 | 1.42x | CN¥285.09 Million | CN¥201.37 Million | ▲ +143.3% |
| 2017 | -3.27x | CN¥-301.20 Million | CN¥92.06 Million | ▼ -122.4% |
| 2016 | 14.60x | CN¥384.51 Million | CN¥26.35 Million | ▲ +2503.4% |
| 2014 | 0.56x | CN¥46.99 Million | CN¥83.82 Million | ▼ -92.1% |
| 2012 | 7.05x | CN¥86.09 Million | CN¥12.21 Million | ▲ +57.8% |
| 2010 | 4.47x | CN¥255.96 Million | CN¥57.27 Million | ▲ +245.5% |
| 2009 | 1.29x | CN¥615.91 Million | CN¥476.08 Million | ▼ -34.7% |
| 2008 | 1.98x | CN¥709.03 Million | CN¥357.94 Million | ▼ -53.1% |
| 2007 | 4.23x | CN¥198.56 Million | CN¥46.99 Million | ▲ +178.2% |
| 2006 | -5.40x | CN¥-106.00 Million | CN¥19.63 Million | ▼ -164.7% |
| 2005 | 8.34x | CN¥111.40 Million | CN¥13.35 Million | ▼ -67.9% |
| 2004 | 25.96x | CN¥211.06 Million | CN¥8.13 Million | ▼ -2.3% |
| 2003 | 26.57x | CN¥230.08 Million | CN¥8.66 Million | ▲ +72.0% |
| 2002 | 15.45x | CN¥157.41 Million | CN¥10.19 Million | ▲ +98.1% |
| 2001 | 7.80x | CN¥78.84 Million | CN¥10.11 Million | ▲ +522.4% |
| 2000 | 1.25x | CN¥36.13 Million | CN¥28.84 Million | ▼ -0.5% |
| 1999 | 1.26x | CN¥54.62 Million | CN¥43.38 Million | ▲ +1233.2% |
| 1998 | -0.11x | CN¥-7.59 Million | CN¥68.35 Million | — |